Short Bowel Syndrome, also known as short gut syndrome, is related to congenital short bowel syndrome and intestinal pseudo-obstruction, and has symptoms including pain, postoperative and postoperative nausea and vomiting. An important gene associated with Short Bowel Syndrome is CLMP (CXADR Like Membrane Protein), and among its related pathways/superpathways are GPCR downstream signalling and Class A/1 (Rhodopsin-like receptors). The drugs Ursodeoxycholic acid and Carbamide peroxide have been mentioned in the context of this disorder. Affiliated tissues include small intestine and colon, and related phenotypes are homeostasis/metabolism and nervous system